AbbVie
Budget
€1 — €0
EP Access
4
accredited persons
Staff
7
2.45 FTE
EU Grants
None
Mission & Goals
AbbVie is a Specialty-focused, research-based biopharmaceutical company focused on developing new products and new ways to help people manage some of the most serious health conditions. We are scientists, researchers, communicators, manufacturing specialists, and regulatory experts. AbbVie began as the pharmaceutical leader, Abbott, which was founded in 1888 by Chicago physician, Dr. Wallace Abbott. Since then, Abbott has evolved to become a global healthcare leader, delivering innovative pharmaceutical, nutritional, diagnostic, and medical products to people in more than 150 countries. On January 1, 2013, AbbVie was founded, a global biopharmaceutical company with the focus and capabilities to address some of the world's greatest health challenges. AbbVie has the stability, resources, expertise, and passion to discover, develop, and bring to market groundbreaking science to solve the biggest health problems that face the world today (...)
EU Legislative Interests
- Pharmaceutical Strategy, and in particular review of the basic pharmaceutical legislation - European Health Data Space - Industrial Policies, and in particular questions around patents, SPC and so on. - Competition in the pharmaceutical sector - Revision of Medical Device and IVD Regulation - Urban Wastewater Directive - PFAS - Packaging and Packaging Waste Directive - European Commission activities around ensuring effective, resilient and sustainable healthcare systems - Access to Medicines - Beating cancer plan - Omnibus Legislation - EU HTA Regulation - Clinical Trials Regulation - Critical Medicines Act - EU Life Sciences Strategy - EU Biotech Act - Women's health - Brain health related initiatives
Communication Activities
AbbVie has supported a number of roundtables that were hosted by members of the European Parliament, speaking engagements at third party conferences, and has also participated in the EU public debate through op-eds that were published in the relevant trade press.
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
- American Chamber of Commerce to the EU - European Federation of Pharmaceutical Industries and Association (EFPIA)
Organisation Members
- European Cancer Organization - European Brain Council
Additional Information
Since 2022 and the new interinstitutonal agreement and the guidelines issued in that context, the reporting structure has changed. This led to adding additional employees and their salaries whose activities are now considered in-scope, as well as to counting the membership fees to organization we are members of (which we previously excluded to avoid double reporting).
Commissioner Meetings
No recorded meetings with EU commissioners.